Add this topic to your myFT Digest for news straight to your inbox
Albert Bourla believes it is ‘feasible’ to inoculate at least 10% of people in every country
Scaling up manufacturing is the best way to inoculate the world and end the pandemic
Manufacturers know Covid-19 jabs are the wrong arena for currying political favour
We must not send the wrong message to pharma companies that have taken huge risks
Trade association chief argues the case for differentiated pricing
International Edition